Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 160,575 | 121,989 | N/A |
| Marketable Securities | 356,066 | 99,848 | N/A |
| TOTAL | $535,390 | $234,365 | $N/A |
| Non-Current Assets | |||
| PPE Net | 27,837 | 29,151 | N/A |
| Other Non-Current Assets | 62,510 | 66,666 | 0 |
| TOTAL | $90,347 | $95,817 | $N/A |
| Total Assets | $625,737 | $330,182 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 7,617 | 3,837 | 0 |
| Accrued Expenses | 19,267 | 42,164 | N/A |
| Other current liabilities | 3,883 | 4,311 | N/A |
| TOTAL | $58,389 | $82,203 | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 17,244 | 21,194 | N/A |
| Other Non-Current Liabilities | 49,356 | 856,525 | 2,629 |
| TOTAL | $52,547 | $863,944 | $N/A |
| Total Liabilities | $110,936 | $946,147 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 128,193 | N/A | N/A |
| Common Shares | 128 | 33 | N/A |
| Retained earnings | -737,739 | -676,293 | N/A |
| Other shareholders' equity | 24 | 106 | 0 |
| TOTAL | $514,801 | $-615,965 | $N/A |
| Total Liabilities And Equity | $625,737 | $330,182 | $0 |